MMSI - Merit Medical Systems, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
South Jordan,
United States
Type: Equity
MMSI price evolution
MMSI
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $636.66 | $581.92 | $587.04 | |
| Short term investments | ||||
| Net receivables | $213.34 | $193.03 | $191.64 | $188.4 |
| Inventory | $310.53 | $298.22 | $302.73 | $303.87 |
| Total current assets | $1078.32 | $1162.55 | $1105.28 | $1108.47 |
| Long term investments | ||||
| Property, plant & equipment | $458.52 | $455.84 | $456.3 | $446.57 |
| Goodwill & intangible assets | $645.63 | $658.62 | $666.24 | |
| Total noncurrent assets | $1209.29 | $1221.08 | $1216.77 | |
| Total investments | ||||
| Total assets | $2378.08 | $2371.84 | $2326.35 | $2325.24 |
| Current liabilities | ||||
| Accounts payable | $60.81 | $55.57 | $48.38 | $65.94 |
| Deferred revenue | $1.55 | $1.58 | $1.6 | |
| Short long term debt | $11.74 | $12.47 | $12.09 | |
| Total current liabilities | $201.08 | $186.22 | $183.34 | $203.56 |
| Long term debt | $750.5 | $859.36 | $860.28 | $879.27 |
| Total noncurrent liabilities | $903.18 | $902.82 | $919.68 | |
| Total debt | $871.1 | $872.75 | $891.36 | |
| Total liabilities | $1054.68 | $1089.39 | $1086.16 | $1123.24 |
| Shareholders' equity | ||||
| Retained earnings | $667.59 | $639.15 | $603.42 | $575.18 |
| Other shareholder equity | -$13.39 | -$15.43 | -$12.46 | -$11.33 |
| Total shareholder equity | $1282.44 | $1240.19 | $1202 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $587.04 | $58.41 | $67.75 | $56.92 |
| Short term investments | ||||
| Net receivables | $188.4 | $178.45 | $170.06 | $154.41 |
| Inventory | $303.87 | $265.99 | $221.92 | $198.02 |
| Total current assets | $1108.47 | $529.08 | $482.21 | $429.71 |
| Long term investments | ||||
| Property, plant & equipment | $446.57 | $448.24 | $437.57 | $460.97 |
| Goodwill & intangible assets | $666.24 | $597.34 | $638.57 | $681.59 |
| Total noncurrent assets | $1216.77 | $1134.88 | $1166.08 | $1234.69 |
| Total investments | ||||
| Total assets | $2325.24 | $1663.97 | $1648.29 | $1664.4 |
| Current liabilities | ||||
| Accounts payable | $65.94 | $68.5 | $55.62 | $49.84 |
| Deferred revenue | $1.6 | $1.71 | $1.81 | $1.92 |
| Short long term debt | $12.09 | $22.25 | $19.11 | $20.4 |
| Total current liabilities | $203.56 | $220.65 | $236.28 | $185 |
| Long term debt | $879.27 | $186.76 | $295.92 | $414.66 |
| Total noncurrent liabilities | $919.68 | $298.92 | $372.21 | $520.82 |
| Total debt | $891.36 | $268.75 | $315.03 | $435.07 |
| Total liabilities | $1123.24 | $519.57 | $608.5 | $705.82 |
| Shareholders' equity | ||||
| Retained earnings | $575.18 | $480.77 | $406.26 | $357.8 |
| Other shareholder equity | -$11.33 | -$11.55 | -$7.99 | -$5.45 |
| Total shareholder equity | $1202 | $1144.4 | $1039.8 | $958.58 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $338 | $323.51 | $324.51 | |
| Cost of revenue | $176.9 | $171.79 | $173.99 | |
| Gross Profit | $161.1 | $151.72 | $150.53 | |
| Operating activities | ||||
| Research & development | $20.26 | $21.48 | $21.64 | |
| Selling, general & administrative | $94.58 | $94.43 | $95.75 | |
| Total operating expenses | $115.15 | $115.79 | $116.92 | |
| Operating income | $45.95 | $35.92 | $33.61 | |
| Income from continuing operations | ||||
| EBIT | $53.52 | $42.39 | $36.44 | |
| Income tax expense | $10.12 | $6.11 | $3.84 | |
| Interest expense | $7.68 | $8.05 | $4.98 | |
| Net income | ||||
| Net income | $35.73 | $28.24 | $27.63 | |
| Income (for common shares) | $35.73 | $28.24 | $27.63 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1257.37 | $1150.98 | $1074.75 | $963.88 |
| Cost of revenue | $673.49 | $631.88 | $589.42 | $562.7 |
| Gross Profit | $583.87 | $519.1 | $485.33 | $401.18 |
| Operating activities | ||||
| Research & development | $82.73 | $75.51 | $71.25 | $57.54 |
| Selling, general & administrative | $373.68 | $342.52 | $335.69 | $297.72 |
| Total operating expenses | $459.93 | $431.54 | $424.42 | $402.74 |
| Operating income | $123.94 | $87.56 | $60.92 | -$1.56 |
| Income from continuing operations | ||||
| EBIT | $127.6 | $88.97 | $59.18 | -$3.24 |
| Income tax expense | $17.68 | $8.11 | $5.46 | -$3.39 |
| Interest expense | $15.51 | $6.34 | $5.26 | $9.99 |
| Net income | ||||
| Net income | $94.41 | $74.52 | $48.45 | -$9.84 |
| Income (for common shares) | $94.41 | $74.52 | $48.45 | -$9.84 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $35.73 | $28.24 | $27.63 | |
| Operating activities | ||||
| Depreciation | $27.03 | $26.72 | $26.31 | |
| Business acquisitions & disposals | -$5.15 | -$3.35 | $0.43 | |
| Stock-based compensation | $7.01 | $5.23 | $5.99 | |
| Total cash flows from operations | $68.51 | $36.22 | $62.25 | |
| Investing activities | ||||
| Capital expenditures | -$10.63 | -$11.68 | -$7.12 | |
| Investments | -$6.16 | |||
| Total cash flows from investing | -$154.21 | -$16.49 | -$22.05 | -$8.34 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.2 | $7.73 | $4.14 | |
| Net borrowings | -$24.06 | $535.27 | ||
| Total cash flows from financing | -$62.44 | $3.14 | -$18 | $472.81 |
| Effect of exchange rate | $0.72 | -$0.43 | -$1.32 | $1.7 |
| Change in cash and equivalents | -$63.87 | $54.73 | -$5.16 | $528.41 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $94.41 | $74.52 | $48.45 | -$9.84 |
| Operating activities | ||||
| Depreciation | $101.29 | $92.2 | $95.78 | $106.82 |
| Business acquisitions & disposals | -$137.85 | -$9.26 | -$7.17 | -$9.67 |
| Stock-based compensation | $21.33 | $18.04 | $16.09 | $14.34 |
| Total cash flows from operations | $145.15 | $114.29 | $147.23 | $165.27 |
| Investing activities | ||||
| Capital expenditures | -$34.09 | -$44.96 | -$26.9 | -$45.95 |
| Investments | $2 | $0.25 | ||
| Total cash flows from investing | -$175.35 | -$57.4 | -$37.16 | -$58.65 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $15.58 | $20.07 | $21.31 | $6.63 |
| Net borrowings | $618.9 | -$44.94 | -$108.5 | -$88.38 |
| Total cash flows from financing | $559.27 | -$60.26 | -$98.44 | -$95.71 |
| Effect of exchange rate | -$0.48 | -$3.83 | -$0.8 | $1.68 |
| Change in cash and equivalents | $528.59 | -$7.19 | $10.83 | $12.6 |
News
Fundamentals
| Market cap | $6.08B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 58.27M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.93 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.36 |
| Quick ratio | 3.82 |